Joshua Woolley
Overview
Explore the profile of Joshua Woolley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
233
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Downey A, Bradley E, Lerche A, ODonovan A, Krystal A, Woolley J
Psychedelic Med (New Rochelle)
. 2025 Mar;
2(2):61-73.
PMID: 40051581
Background: As the field of psychedelic therapy grows, it is vital to consider who can safely engage with psilocybin therapy. In most modern clinical trials of psilocybin therapy, individuals with...
2.
Haft S, Downey A, Raymond-Flesch M, Fernandes-Osterhold G, Bradley E, ODonovan A, et al.
Psychiatry Res
. 2025 Jan;
345:116359.
PMID: 39823947
A lack of diverse and representative participant samples in mental health intervention research perpetuates mental health disparities. This issue has become a salient concern in studies of psychedelic-assisted psychotherapy (PAT),...
3.
Downey A, Chaphekar A, Woolley J, Raymond-Flesch M
J Eat Disord
. 2024 Apr;
12(1):49.
PMID: 38659049
Background: Clinical trials using psilocybin therapy to treat anorexia nervosa (AN) are currently underway. The safety and tolerability of psilocybin is of utmost importance in individuals with AN who may...
4.
Raison C, Sanacora G, Woolley J, Heinzerling K, Dunlop B, Brown R, et al.
JAMA
. 2023 Aug;
330(9):843-853.
PMID: 37651119
Importance: Psilocybin shows promise as a treatment for major depressive disorder (MDD). Objective: To evaluate the magnitude, timing, and durability of antidepressant effects and safety of a single dose of...
5.
Downey A, Boyd M, Chaphekar A, Woolley J, Raymond-Flesch M
Int J Eat Disord
. 2023 Aug;
56(11):2142-2148.
PMID: 37551650
Objective: This study invited providers who care for patients with eating disorders to inform engagement, communication, and collaboration with psilocybin-assisted psychotherapy interventions. Method: Medical and mental health providers who treat...
6.
Park J, Woolley J, Mendes W
Front Psychol
. 2022 Sep;
13:916305.
PMID: 36059785
Social acceptance (vs. rejection) is assumed to have widespread positive effects on the recipient; however, ethnic/racial minorities often react to social acceptance by White individuals. One possibility for such reactions...
7.
Khan A, Bradley E, ODonovan A, Woolley J
Curr Top Behav Neurosci
. 2022 Jun;
56:319-332.
PMID: 35711024
Posttraumatic stress disorder (PTSD) is a debilitating, chronic disorder and efficacy rates of current PTSD treatments are underwhelming. There is a critical need for innovative approaches. We provide an overview...
8.
Stauffer C, Anderson B, Ortigo K, Woolley J
ACS Pharmacol Transl Sci
. 2021 Apr;
4(2):526-532.
PMID: 33860182
Attachment insecurity is determined early in life, is a risk factor for psychopathology, and can be measured on two separate continuous dimensions: attachment anxiety and attachment avoidance. Therapeutic changes toward...
9.
Anderson B, Danforth A, Daroff P, Stauffer C, Ekman E, Agin-Liebes G, et al.
EClinicalMedicine
. 2020 Nov;
27:100538.
PMID: 33150319
Background: Psilocybin therapy has shown promise as a rapid-acting treatment for depression, anxiety, and demoralization in patients with serious medical illness (e.g., cancer) when paired with individual psychotherapy. This study...
10.
Flanagan J, Mitchell J, Baker N, Woolley J, Wangelin B, Back S, et al.
Contemp Clin Trials
. 2020 Jun;
95:106074.
PMID: 32561468
Posttraumatic stress disorder (PTSD) is the most highly prevalent mental health disorder among U.S. military Veterans. Prolonged Exposure (PE) therapy is one of the most widely used evidence-based treatments for...